Novel D-Peptide Design Targets Influenza Virus Hemagglutinin

Rapid Summary

• The Proceedings of the National Academy of Sciences,Volume 122,Issue 26 (July 2025),highlights advancements in peptide research.
• The publication introduces a computational strategy for de novo design of D-peptides.
• D-peptides are considered superior to L-peptides due to improved metabolic stability and immunogenicity properties.
• The article addresses limitations in current methods for finding and screening.

Read more

Indian Opinion Analysis
India’s pharmaceutical and biotechnology sectors have seen rapid growth over recent years, making the innovation outlined in this study particularly relevant. Improved methods for designing D-peptides could bolster drug progress initiatives by enhancing pharmaceutical efficacy and reducing costs associated with stability issues or immune system reactions common with L-peptides. As India continues to build its capacity in biotechnological research,adopting cutting-edge computational strategies like those described here could enhance its global competitiveness-especially given the ongoing push for self-reliance (“Atmanirbhar Bharat”) in critical areas such as healthcare innovations.